FIELD: medicine.
SUBSTANCE: viral load (VL) of HHV-6 DNA is determined by polymerase chain reaction (PCR) in the scraping of the oropharyngeal epithelium in a child before the start of therapy, then one and three months after the start of treatment, and with a VL decrease through the indicated time intervals by 2 log10 and more, high effectiveness of therapy is concluded; with a VL decrease by 1 log10 - moderate effectiveness of therapy is concluded.
EFFECT: objectivity, increased method sensitivity, non-invasiveness.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSMENT OF ACTIVITY OF INFECTION CAUSED BY HERPES TYPE 4, 5 AND 6 IN CHILDREN | 2016 |
|
RU2639593C1 |
| METHOD OF ASSESSING THERAPY EFFECTIVENESS FOR INFECTION CAUSED BY EPSTEIN-BARR VIRUS IN CHILDREN | 2016 |
|
RU2618391C1 |
| METHOD FOR PREDICTING HUMAN TYPE 6 HERPES VIRUS INFECTION IN CHILDREN | 2018 |
|
RU2695323C1 |
| METHOD FOR DETERMINATION OF INDICATIONS FOR ANTIHERPETIC THERAPY IN CASE OF HHV-6 INFECTION IN CHILDREN WITH ACUTE RESPIRATORY DISEASES | 2017 |
|
RU2641609C1 |
| METHOD OF ESTIMATING EFFICIENCY OF THERAPY OF CHRONIC CYTOMEGALOVIRAL INFECTION IN CHILDREN | 2014 |
|
RU2566074C1 |
| DIAGNOSTIC TECHNIQUE FOR THE COMBINED INFECTION IN CHILDREN WITH ACUTE RESPIRATORY INFECTIONS | 2019 |
|
RU2706126C1 |
| METHOD FOR DETECTING AND LABORATORY CONFIRMATION OF INHERITED CHROMOSOMALLY-INTEGRABLE HUMAN HERPES VIRUS 6A/B | 2020 |
|
RU2739997C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF LATENT AND ACTIVE FORMS OF HHV-6 INFECTION IN CHILDREN | 2023 |
|
RU2817089C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF CNS ORGANIC LESIONS IN CHILDREN WITH HERPES VIRAL INFECTIONS | 2019 |
|
RU2729988C1 |
| METHOD FOR ASSESSING EFFECTIVENESS OF ANTIVIRAL THERAPY IN INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2023 |
|
RU2823996C1 |
